MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Novacyt products included in UK testing framework for Covid-19 variants

StockMarketWire.com

Diagnostics group Novacyt said its Covid-19 testing products had been included in a UK framework for identifying variants of the disease.

The company's SARS-CoV-2 polymerase chain reaction genotyping portfolio had been included in the NHS England Framework for detecting variants of concern.

Novacyt also announced the launch of two new PCR assays to detect SARS-CoV-2 variants of concern.

At 8:06am: (LON:NCYT) Novacyt S.A. share price was 0p at 897p


Story provided by StockMarketWire.com